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Tetraspanins are 
involved in Burkholderia 
pseudomallei┽induced 
cell┽to┽cell fusion of phagocytic 
and non┽phagocytic cells
Tanes Sangsriの┸ Natnaree Saipromの┸ Alisa Tubsuwanは┸ Peter Monkば┸ Lynda J┻ Partridgeぱ ┃ 
Narisara Chantratitaの┸ひ*
Tetraspanins are four┽span transmembrane proteins of host cells that facilitate infections by many 
pathogens┻ Burkholderia pseudomallei is an intracellular bacterium and the causative agent of 
melioidosis┸ a severe disease in tropical regions┻ This study investigated the role of tetraspanins in 
B. pseudomallei infection┻ We used ━ow cytometry to determine tetraspanins CDぶ┸ CDびば┸ and CDふの 
expression on Aひぱぶ and JぴぴぱA┻の cells┻ Their roles in B. pseudomallei infection were investigated 
in vitro using monoclonal antibodies ゅMAbsょ and recombinant large extracellular loop ゅECはょ proteins 
to pretreat cells before infection┻ Knockout of CDぶ and CDふの in cells was performed using CRISPR 
Casぶ to conボrm the role of tetraspanins┻ Pretreatment of Aひぱぶ cells with MAb against CDぶ and 
CDぶ┽ECは signiボcantly enhanced B. pseudomallei internalization┸ but MAb against CDふの and CDふの┽ECは 
inhibited MNGC formation┻ Reduction of MNGC formation was consistently observed in Jぴぴぱ┻Aの cells 
pretreated with MAbs speciボc to CDぶ and CDふの and with CDぶ┽ECは and CDふの┽ECは┻ Data from knockout 
experiments conボrmed that CDぶ enhanced bacterial internalization and that CDふの inhibited MNGC 
formation┻ Our data indicate that tetraspanins are host cellular factors that mediated internalization 
and membrane fusion during B. pseudomallei infection┻ Tetraspanins may be the potential therapeutic 
targets for melioidosis┻
Tetraspanins are a superfamily of four-span transmembrane proteins distributed in multicellular  organisms1. 
he proteins consist of four transmembrane domains, which can generate a protein structure containing one 
small extracellular loop (EC1) and one large extracellular loop (EC2). he function of tetraspanins depends on 
their ability to be laterally associated with the partner molecules, e.g., immunoglobulin superfamily members, 
integrins, and signalling molecules, to form functional assemblies as termed tetraspanin enriched microdomains 
(TEMs)2,3. Evidence is emerging and suggesting that TEMs are involved in many infectious diseases caused by 
viruses, bacteria, and protozoa and may act as gateways for  infections3,4. TEMs may participate in various stages 
of infective processes, from facilitating binding to activating signalling pathways. Disruption of the TEM function 
may disorganize many potential receptors and interferes with the binding site of pathogens. Novel anti-infections 
targeting tetraspanins is a new strategy to inhibit the process of these infections.
Burkholderia pseudomallei is the causative agent of melioidosis, a fatal disease in tropical regions, endemic in 
Southeast Asia, and northern  Australia5. he predicted burden of disease is about 165,000 cases, which includes 
89,000  deaths6. he clinical manifestation of melioidosis ranges from acute to chronic infections with pneumonia 
and septicaemia being the most common  presentations7. he mortality rate is 10 to 50% worldwide, and approxi-
mately 35% in hailand. he death from melioidosis is oten caused by delays in treatment or because of com-
plications in clinical recognition and  diagnosis5,8,9. Due to the high mortality rate, intrinsic antibiotic resistance, 
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low infectious dose, aerosol route of infection, and no vaccine available, melioidosis is a public health concern in 
tropical countries. B. pseudomallei is an environmental bacterium, but it is classiied as a CDC tier 1 select agent, 
a potential biothreat. It can infect humans and animals by inoculation, inhalation, and ingestion. B. pseudomallei 
can infect and survive within either phagocytic or non-phagocytic cells. Ater infection, the bacteria multiply 
in the cytoplasm and induce cell-to-cell fusion or multinucleated giant cell formation (MNGC). his process is 
crucial for spreading from infected cells to neighbouring cells. In this way, the bacteria can avoid exposure to host 
immune response or  antibiotics10. Once the infection is established, B. pseudomallei may disseminate to many 
 organs5. Although B. pseudomallei has been reported to use several virulence factors for invasion, the potential 
host molecules that contribute to bacterial and host interactions are poorly understood.
B. thailandensis is a closely-related species of B. pseudomallei. B. thailandensis can infect both phagocytic 
and non-phagocytic cells and subsequently induce MNGC formation in vitro similar to B. pseudomallei10,11. 
Tetraspanins have been widely implicated in the regulation of various cell: cell fusion processes, including viral 
syncytium  formation12–15. We have also recently demonstrated that reagents targeting tetraspanins CD9, CD63, 
and CD81 could afect B. thailandensis-induced MNGC in mouse macrophage cell lines. In brief, recombinant 
proteins corresponding to the EC2s of these tetraspanins inhibited MNGC formation while antibodies to CD9 
and CD81 enhanced MNGC formation, and a macrophage cell line generated from a CD9KO mouse showed 
enhanced MNGC  formation16. his led us to hypothesize that tetraspanins might play a role in B. pseudomallei 
infection and bacterial spreading between host cells during melioidosis.
In order to investigate the role of tetraspanins in B. pseudomallei infection, we used monoclonal antibodies 
(MAbs) speciic to the large extracellular EC2 domain of tetraspanins and recombinant EC2 proteins of CD9, 
CD63, and CD81 to pretreat a human epithelial cell line A549 and a mouse macrophage cell line J774A.1 before 
infection. Mouse macrophage cell lines have been widely used as the in vitro model for B. pseudomallei and B. 
thailandensis infection and MNGC  formation16–21. he mouse tetraspanin CD9 is about 90% homology to Homo 
sapiens CD9 and has been used to represent mammalian cells in sperm-egg fusion  assay22,23. We determined the 
expression of tetraspanins on host cells by low cytometry and assessed the number of bacterial adhesion and 
internalization to these cells by colony count. MNGC formation and MNGC size of infected cells was determined 
by imaging analyses using light microscopy and confocal microscopy. We also performed tetraspanin genes knock 
out on cells using the CRISPR/Cas9 system and conirmed a role for host tetraspanins for B. pseudomallei infec-
tion. Finally, the role of tetraspanins for infections was compared between B. pseudomallei and B. thailandensis.
Results
Expression of tetraspanins on uninfected Aひぱぶ and JぴぴぱA┻の cells┻ he role of tetraspanins in 
B. pseudomallei infection and MNGC formation were investigated in two cell lines. A549 represented a non-
phagocytic human epithelial cell, and J774A.1 represented a phagocytic mouse macrophage cell. To determine if 
tetraspanins are expressed on the cell surface of the cells, we used low cytometry and antibodies that recognise 
CD9, CD63, and CD81. We observed in both A549 and J774A.1 that the MFI level of cells treated with antibod-
ies against CD9 and CD81 were signiicantly higher than those treated with isotype controls (Supplementary 
Fig. S1). In contrast, the MFI level of cells treated with the antibody against CD63 was not diferent from isotype 
controls. hese results indicated that CD9 and CD81 expressed on A549 and J774A.1 at a relatively high level but 
that CD63 was poorly expressed on the cell surface.
Expression of tetraspanins on B. pseudomallei infected Aひぱぶ and JぴぴぱA┻の cells┻ We next inves-
tigated the level of these tetraspanins expression on A549 and J774A.1 cells during B. pseudomallei infection. We 
used low cytometry and speciic antibodies to determine CD9, CD63, and CD81 expressions on cells at 1, 4, and 
12 h ater infection at MOI 100 or 30. he result showed that expressions of CD9, CD63, and CD81 on both cells 
were not signiicantly diferent between B. pseudomallei infected cells and non-infected cells at all-time points 
(Supplementary Fig. S2). hese results demonstrate that B. pseudomallei infections did not alter CD9, CD63, and 
CD81 expression on these cells.
Eプect of anti┽tetraspanin MAbs and recombinant ECは proteins on B. pseudomallei adhesion 
and internalization┻ To determine the role of tetraspanins in B. pseudomallei adhesion and internalization 
in A549 and J774A.1 cells, we used MAbs speciic to tetraspanins as well as recombinant EC2 proteins to treat 
cells for 1 h before infection. he controls were cells incubated with PBS or IgG isotype-matched MAbs or GST. 
he result showed no diference in bacterial adherence between cells pretreated with these reagents and isotype 
controls or PBS in both cell types (Supplementary Fig. S3). Since J774A.1 cells are capable of phagocytosis, we 
considered that the measurement of associated bacteria at this point might be both bacterial adhesion and inter-
nalization. We, therefore, investigated the role of tetraspanin in adhesion in J774A.1 ater blocking phagocytosis 
with 2 µg/ml cytochalasin  D17. he result also showed no signiicant diference in adherence between J774A.1 
cells pretreated with anti-tetraspanin MAbs and isotype controls or PBS, which was similar to the result of the 
experiment without cytochalasin D. he data suggest that tetraspanins are not involved in bacterial adhesion in 
J774A.1 cells (Supplementary Fig. S4). For internalisation, only pre-treatment with anti-CD9 MAb and CD9-
EC2 signiicantly increased the percentage of bacterial internalisation into A549 cells (P = 0.003 for anti-CD9 
MAb; P = 0.002 for CD9-EC2) (Fig. 1A,B). In contrast, none of these MAbs or EC2 proteins inhibited B. pseu-
domallei internalisation in J774.A1 cells. he data suggest diferent roles of CD9 for bacterial uptake between 
A549 and J774.1 cells.
Eプect of anti┽tetraspanin MAbs and recombinant ECは proteins on B. pseudomallei┽induced 
MNGC formation┻ Anti-tetraspanin MAbs and recombinant EC2 proteins were used to investigate the role 
ば
Vol.:(0123456789)
Scientiボc Reports |        (2020) 10:17972  | https┺【【doi┻org【のね┻のねばふ【sぱのひぶふ┽ねはね┽ぴぱぴばぴ┽y
www.nature.com/scientificreports/
of tetraspanins during B. pseudomallei-induced MNGC formation in A549 and J774A.1 at 12 h post-infection. 
In A549 cells, the number of MNGC formation and MNGC size of cells treated with MAbs against CD9 and 
CD63 and their EC2 proteins were not diferent from those treated with isotype or GST controls (Figs. 2, 3A,B). 
Interestingly, treatment with MAb speciic to CD81 and CD81-EC2 signiicantly inhibited the number of B. 
pseudomallei-induced MNGC formation by 68.3% and 53.8% (P < 0.001 for both comparisons), respectively 
(Figs. 2, 3A,B) and reduced in MNGC size by 60.1% (P < 0.001) and 41.1% (P = 0.003), respectively compared 
with cells treated with isotype-matched controls or GST control (Figs. 2, 3C,D).
In contrast, pretreatment of J774A.1 cells with MAbs against both CD9 and CD81 signiicantly inhibited 
the number of MNGC formation by 61.9% and 53.0% (P < 0.001 for both comparisons) (Figs. 2 and 3E) and 
reduced in MNGC size by 60.8% and 42.4% (P = 0.001), respectively when compared with cells treated with 
isotype controls (Figs. 2 and 3G). Likewise, cells treated with CD9-EC2 and CD81-EC2 signiicantly inhibited B. 
pseudomallei-induced MNGC formation by 42.4% (P = 0.001) and 31.5% (P = 0.003) compared with GST control 
(Figs. 2 and 3F). However, cells treated with CD9-EC2 and CD81-EC2 showed a reduction in MNGC size when 
compared with GST control (Fig. 2), but the results were not statistical signiicance (Fig. 3H).
To investigate whether the inhibition of B. pseudomallei-induced MNGC formation by CD9-EC2 and CD81-
EC2 may increase at higher EC2 concentrations, pretreatments of J774A.1 were performed with CD9-EC2 and 
CD81-EC2 at 10, 20, 50, and 100 µg/ml. We did not observe diferent MNGC formation between cells treated with 
PBS or GST control and those pretreated with ten µg/ml CD9-EC2, but there was a decrease in MNGC forma-
tion when cells were treated with 20, 50, and 100 µg/ml of CD9-EC2 concentrations (Supplementary Fig. S5A). 
We further tested the efect of combined CD9-EC2 and CD81-EC2 pretreatment in J774A.1 cells, but there was 
no increase in inhibitory efect from the results of pretreatment with CD9-EC2 alone or with CD81-EC2 alone 
(Supplementary Fig. S5B).
We next conirmed the role tetraspanins in B. pseudomallei-induced MNGC formation by treating the cells 
with anti-tetraspanin MAbs at 5 h post-infection, the time in which ater bacterial internalization and before 
MNGC formation took place. Nevertheless, we observed no diferent results from those of adding anti-MAbs 
before infection (Supplementary Fig. S6). Furthermore, Giemsa staining of MNGC revealed that B. pseudomallei 
Figure 1.  Efect of anti-tetraspanin MAbs and recombinant EC2 proteins pretreatment on B. pseudomallei 
K96243 internalisation to A549 and J774A.1 cells. he internalisation of B. pseudomallei K96243 to A549 cells 
(A,B) and J774A.1 (C,D) were performed at MOI of 100 and 30. A and C show the efect of anti-tetraspanin 
MAbs. (B,D) show the efect of recombinant EC2 protein pretreatment. Data represent individual scatter plots 
and the mean ± standard deviation from three independent experiments; each experiment was performed in 
triplicate. Dashed lines represent P values of ANOVA test, and solid lines represent P value of t tests. he graphs 
were created using GraphPad Prism sotware version 6.0 (GraphPad Sotware Inc, La Jolla, CA).
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were able to multiply in the cytosol of A549 cells pretreated with anti-CD81 antibody or J774A.1 cells pre-
treated with anti-CD9 antibody similar to those cells pretreated with isotype-matched controls (Supplementary 
Fig. S7). Altogether, our data conirmed that CD9 and CD81 tetraspanins are involved in cell fusion induced 
by B. pseudomallei.
Figure 2.  Giemsa-stained A549 cells (A–I) and J774A.1 cells (J–R) following B. pseudomallei infection. Cells 
were pretreated with anti-tetraspanin MAbs or isotype controls before infection. Cells were ixed, stained, and 
observed for MNGC formation at 12 h post-infection using a 20 × objective lens. Arrow indicates MNGC. he 
images were combined using BioRender.com (https ://app.biore nder.com).
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The localisation of tetraspanin during B. pseudomallei┽induced MNGC formation┻ Since we 
observed that CD9 and CD81 were involved with MNGC formation induced by B. pseudomallei in J774A.1 
and CD81 signiicantly involved in this process in A549 cells, we determined (1) CD9 and CD81 localisation in 
J774A.1 and (2) CD81 localisation in A549 cells during B. pseudomallei-induced MNGC formation by immu-
noluorescence staining and confocal microscopy. CD9 and CD81 were examined using speciic antibodies and 
LSM, Z-stack analysis. In uninfected cells, immunoluorescence staining showed that CD9 and CD81 distrib-
Figure 3.  MNGC formation of A549 and J774A.1 cells induced by B. pseudomallei K96243 infection. A549 and 
J774A.1 cells were infected with B. pseudomallei at MOI of 100 and 30. Efect of anti-tetraspanin MAbs (A) and 
recombinant EC2 proteins (B) pretreatment on B. pseudomallei-induced MNGC formation of A549 cells. Efect 
of anti-tetraspanin MAbs (C) and recombinant EC2 proteins (D) pretreatment on average MNGC size of A549 
cells. Efect of anti-tetraspanin MAbs (E) and recombinant EC2 proteins (F) pretreatment on B. pseudomallei-
induced MNGC formation to J774A.1 cells. Efect of anti-tetraspanin MAbs (G) and recombinant EC2 proteins 
(H) pretreatment on average MNGC size of J774A.1 cells. Data represent individual scatter plots and the 
mean ± standard deviation from three independent experiments; each experiment was performed in triplicate. 
Dashed lines represent P values of ANOVA test, and solid lines represent P value of t tests. he graphs were 
created using GraphPad Prism sotware version 6.0 (GraphPad Sotware Inc, La Jolla, CA).
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uted in all areas of the cells (Fig. 4 and Supplementary Fig. S8). J774A.1 and A549 cells were infected with B. 
pseudomallei K96243. Our investigations revealed the presence of bacteria within the cytoplasm of the infected 
J774A.1 and A549 cells (Fig. 4). CD81 was observed in all areas of infected A549 cells (Fig. 4A), and CD9 was 
distributed in infected J774A1 cells (Fig.  4D). Cells treated with isotype-matched controls were negative for 
CD81 and CD9 (Fig. 4B,E, respectively). he results also demonstrated that tetraspanins CD9 and CD81 were 
located with B. pseudomallei at membrane protrusion ends.
Generation of tetraspanins gene knockout in Aひぱぶ cells┻ To conirm the role of tetraspanins, CD9, 
and CD81 in B. pseudomallei internalization and MNGC formation in A549 and J774A.1 cells, we generated 
CD9 and CD81 gene knock out cell lines using the CRISPR/Cas9 system. sgRNA sequences targeting both 
human and mouse CD9 and CD81 were designed (Fig. 5A) and cloned into the PX459V2.0. A549 or J774A cells 
were transfected with individual plasmids expressing Cas9 and the corresponding sgRNA. As assessed by low 
cytometry, gRNA1 and gRNA2 were able to disrupt CD9 and CD81 expression in A549 cells with eiciencies of 
18% and 35%, respectively (Fig. 5B). Transfection of J774A.1 with the plasmids resulted in massive cell death, 
and the number of living cells was not enough for further analysis.
Only CD9 and CD81 knockout A549 cells were further sorted by FACS. he sorted cells were isolated into 
a single cell by limiting dilution. Two single clones, A549-CD9KO1 and A549-CD81KO2, were expanded and 
selected for further analysis. Flow cytometry analysis conirmed the absence of CD9 and CD81 expression on 
the cell surface of those cells when compared with the unedited control (Fig. 5C). To characterize the nature of 
the mutation in these cells, PCR amplicon spanning the Cas9-sgRNA cleavage site was ampliied from the two 
individual clones and analyzed the products on an agarose gel. Only one PCR fragment was ampliied in the 
A549-CD9KO1 clone, while two PCR fragments were detected in the A549-CD81KO2 clone. he products from 
both A549-CD9KO1 and A549-CD81KO2 clones were smaller than the unedited control DNA, indicating that 
gene deletions were introduced into the genomic sequence of those cells (Fig. 5D and Supplementary Fig. S9). To 
conirm these indings, individual PCR fragments were puriied from the gel and subjected to direct sequencing. 
Sequence from A549-CD9KO1 displayed a 259-bp deletion in the 5ƍ untranslated region of CD9 in both alleles 
(Fig. 5D). his would inhibit CD9 expression via translation control. Two deleted alleles were identiied from 
A549-CD81-KO2 (Fig. 5D). One exhibited a 15-bp deletion in the 5ƍ untranslated region of CD81 gene, which 
would afect its expression. Another allele revealed a 96-bp deletion that generated truncated protein that lacked 
the intracellular N terminal domain and EC1. he lack of EC1 would destabilize EC2 folding and further disrupt 
EC2  function24. he lack of the protein expressions on the cell surface was conirmed by FACs analysis, Western 
blotting (Supplementary Fig. S10), and sequencing analysis, which indicated successful CD9 and CD81 gene 
knock out in A549-CD9KO1 and A549-CD81KO2 cell lines using the CRISPR/Cas9 system.
Eプect of tetraspanins gene knockout on B. pseudomallei internalisation and MNGC forma-
tion┻ he absence of CD9 and CD81 on the A549 cell surface did not show any efect on B. pseudomallei 
adhesion (Fig. 6A). As expected, infection of A549-CD9KO1 cells showed a signiicant increase in the num-
ber of B. pseudomallei internalisation compared with A549 WT cells (Fig. 6B). Moreover, image analyses by 
light microscopy demonstrated that A549-CD81KO2 showed signiicantly decreased B. pseudomallei-induced 
MNGC formation and a reduction of MNGC size (Figs. 6C,D, and 7, respectively). he result of the gene knock-
out experiment on A549 cells was consistent with those of pretreatment with anti-CD9 MAb and anti-CD81 
MAb or recombinant EC2 proteins (Figs. 1, 2, 3). Taken together, these results suggest that tetraspanins CD9 and 
CD81 of host cells play a crucial role in B. pseudomallei internalisation and MNGC formation.
Comparison of the eプect of anti┽tetraspanin MAbs on MNGC formation induced by B. thai-
landensis and B. pseudomallei┻ he inhibition of B. pseudomallei-induced MNGC formation by CD9 
and CD81 GST-EC2 proteins is consistent with their efect on this process in B. thailandensis infected mouse 
 macrophages16. However, our previous report demonstrated that in this system, anti-CD9 and anti-CD81 MAbs 
enhanced MNGC formation, while here, the same antibodies inhibited B. pseudomallei-induced MNGC forma-
tion (Figs. 2 and 3). We, therefore, compared the efect of the anti-tetraspanin MAbs on MNGC formation in 
J774A.1 and A549 cells infected with B. thailandensis and B. pseudomallei K96243. Indeed, the results showed 
diferent efects of anti-CD9 and anti-CD81 MAbs between cells infected with the two Burkholderia species. We 
observed that pretreatment with anti-CD9 and anti-CD81 MAbs enhanced B. thailandensis-induced MNGC 
formation and MNGC size in J774A.1 cells (Figs. 8, 9A,B), consistent with our previous  work16. he results of 
B. pseudomallei infection were the same as in previous experiments (Figs. 2 and 3), demonstrating that in this 
system, anti-CD9 and anti-CD81 MAbs signiicantly inhibited MNGC formation and reduced MNGC size in 
J774A.1 cells (Fig. 9C,D).
In infected A549 cells, pretreatment with anti-CD9 and anti-CD81 MAbs also showed diferent efects on 
MNGC formation between B. thailandensis and B. pseudomallei. he results revealed pretreatment with anti-CD9 
and anti-CD81 MAbs enhanced B. thailandensis-induced MNGC formation cells (Figs. 8 and 9E) and MNGC 
size (Fig. 9F), while pretreatment with anti-CD81 MAb signiicantly inhibited B. pseudomallei-induced MNGC 
formation (Fig. 9G) and decreased MNGC size (Fig. 9H).
Discussion
Here, we demonstrated a role for host tetraspanins in B. pseudomallei internalisation and MNGC formation dur-
ing B. pseudomallei infection in A549 and J774A.1 cell lines. In A549 lung epithelial cells, our results revealed that 
CD9 facilitated B. pseudomallei internalisation and that CD81 inhibited in MNGC formation. By blocking with 
a speciic antibody to CD81 or recombinant CD81-EC2 protein, we found a decrease in the number and size of 
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Figure 4.  Confocal luorescence microscopy z-stack imaging of A549 cells infected with B. pseudomallei 
K96243 at MOI 25 (A) and J774A.1 cells infected with B. pseudomallei K96243 at MOI 10 (D) at 8 h. Z-stack 
images were collected at 4.0-µm sections, and the red and green lines indicate the orthogonal planes of the 
y–z and x–z projections, respectively. Bacteria were stained with anti-B. pseudomallei capsular polysaccharide 
antibody-conjugated Alexa Fluor 488 (green). (B) Shows infected A549 cells stained with an Alexa Fluor 555 
conjugated IgG1 isotype control of mouse anti-human CD81. (E) Shows infected J774A.1 cells stained with an 
Alexa Fluor 555 conjugated IgG2b isotype control of rat anti-mouse CD9. C and F show uninfected A549 and 
J774A.1 cells stained with an Alexa Fluor 555 conjugated mouse anti-human CD81 or rat anti-mouse CD9 (red) 
and nuclei were stained with Hoechst 33,258 (blue). Arrows indicate the position of bacteria and tetraspanins 
during B. pseudomallei-induced cell-to-cell fusion. Bars, 5 µm. Images were visualised using a confocal 
microscope (LSM 700; Carl Zeiss), a 100 × objective. he images were combined using BioRender.com (https ://
app.biore nder.com).
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MNGC in infected cells. We conirmed that CD81 knock out A549 cells, in comparison to A549 wild type, had a 
signiicantly decreased MNGC formation when infected with B. pseudomallei. Our results in mouse macrophage 
J774A.1 cells were diferent from A549 in that both CD9 and CD81 were involved in B. pseudomallei-induced 
Figure 5.  Detection and conirmation of CD9 and CD81 genes knockout by CRISPR/cas9 system. he gRNA 
sequences were consisting of a 20-nucleotides pair with the DNA target, directly upstream of a requisite 5ƍ-NGG 
adjacent motif (PAM; red) (A). he transfection eiciency of CD9 targeting gRNA1 and CD81 targeting gRNA2 
in A549 cells was analysed by low cytometry (B). he expression of CD9 and CD81 on the cell surface was 
analysed by low cytometry, as shown in histogram (C). DNA cleavage by CRISPR/cas9 was detected by PCR 
and conirmed by sequencing (D). he deletion regions are shown in red. he images were combined using 
BioRender.com (https ://app.biore nder.com).
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Figure 6.  he efects of CD9 and CD81 genes knockout of A549 cells on B. pseudomallei infection. A549 
cells were infected with B. pseudomallei at MOI 100 for 1, 4, and 12 h at 37 °C. Efect of gene knockout on B. 
pseudomallei adhesion (A), internalization (B), MNGC formation (C), and MNGC size (D). Data represent 
the mean ± standard deviation Data represent individual scatter plots, and the mean ± standard deviation from 
three independent experiments, each experiment was performed in triplicate. Dashed lines represent P values of 
ANOVA test, and solid lines represent P value of t tests. he graph were created using GraphPad Prism sotware 
version 6.0 (GraphPad Sotware Inc, La Jolla, CA).
Figure 7.  Giemsa-stained A549 cells wild type, A549-CD9KO1, and A549-CD81KO2 following B. pseudomallei 
K96243 infection. Cells were ixed, stained, and observed for MNGC formation at 12 h post-infection using a 
20 × objective lens. Arrows indicate MNGC. he images were combined using BioRender.com (https ://app.biore 
nder.com).
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MNGC formation. By blocking with speciic antibodies or EC2 proteins, we showed a signiicant decrease in 
MNGC formation of infected cells.
he tetraspanins CD9, CD63, and CD81 are known to be widely expressed in mammalian cells, but whereas 
CD9 and CD81 are predominantly expressed on the cell surface, CD63 is mainly distributed in intracellular 
vesicular  compartments25. Our data are consistent with those reports conirming that CD9 and CD81 but not 
CD63 were expressed on the cell surface of A549 and J774A.1 cells.
Figure 8.  Giemsa-stained J774A.1 cells (A–D) and A549 cells (E–H) following B. thailandensis E264 infection. 
Cells were pretreated with anti-tetraspanin MAbs or isotype controls before infection. Cells were ixed, stained, 
and observed for MNGC formation at 12 h post-infection using a 20 × objective lens. Arrows indicate MNGC. 
he images were combined using BioRender.com (https ://app.biore nder.com).
のの
Vol.:(0123456789)
Scientiボc Reports |        (2020) 10:17972  | https┺【【doi┻org【のね┻のねばふ【sぱのひぶふ┽ねはね┽ぴぱぴばぴ┽y
www.nature.com/scientificreports/
Figure 9.  Efect of anti-tetraspanin MAbs on MNGC formation induced by B. thailandensis E264 and 
B. pseudomallei K96243 in J774A.1 and A549 cells. (A,C,E,G) show the efect of anti-tetraspanin MAbs 
pretreatment on MNGC formation. (B,D,F,H) show the efect of anti-tetraspanin MAbs pretreatment on 
average MNGC size. J774A.1 cells were infected with B. thailendensis (A,B) or B. pseudomallei (C,D) at 
MOI 30. A549 cells were infected with B. thailandensis (E,F) or B. pseudomallei (G,H) at MOI 100. Data 
represent individual scatter plots and the mean ± standard deviation from three independent experiments; 
each experiment was performed in triplicate. Dashed lines represent P values of ANOVA test, and solid lines 
represent P value of t tests. he graphs were created using GraphPad Prism sotware version 6.0 (GraphPad 
Sotware Inc, La Jolla, CA).
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Tetraspanins are known to be involved in infections caused by other intracellular pathogens, particularly 
 viruses4,26,27. here is also growing evidence for roles for tetraspanins in bacterial infection; for example, CD81 
has been demonstrated to be involved in Listeria monocygenes invasion into human epithelial  cells28. TEMs 
appear to act as "adhesion platforms" for a wide range of bacteria, and that agents that disrupt TEM can prevent 
bacterial attachment to host  cells29–31. B. pseudomallei employs several virulence factors for adhesion and inva-
sion to host cells such as PilA and adhesion proteins; BoaA and  BoaB32. For invasion, BopE, type III secretion 
system (T3SS) efectors facilitate B. pseudomallei entry into host  cells33. However, our study did not ind that CD9, 
CD63, and CD81 mediate the adherence of B. pseudomallei to epithelial cells and macrophages. he interplay 
between host cells and B. pseudomallei is complex and not very well understood but presumably in macrophage 
uptake is mainly by phagocytosis.
Interestingly, our results demonstrated that anti-CD9 MAb and CD9-EC2 but not CD63 or CD81 reagents 
enhanced B. pseudomallei internalisation into A549 cells. he data suggest that anti-CD9 MAb or CD9-EC2 may 
stabilise or enhance the formation of entry platforms for bacteria. he interaction of CD9 with B. pseudomallei 
components that explains its involvement with bacterial internalisation is currently unknown. Further study is 
required to investigate the role of CD9 as well as other tetraspanins for B. pseudomallei internalisation and to 
identify their partner proteins for the organisation of "entry platforms" for B. pseudomallei infection. Our data 
cannot suggest that overexpression of CD9 in A549 leads to a decrease in internalisation during B. pseudomallei 
infection but data from Hassuna NA et al. suggest that overexpression of CD63 in HEK 293 cells is not suicient 
to promote S. Typhimurium binding to non-phagocytic  cells30.
here was no efect of CD9 or CD81 reagents on J774A.1 cells internalisation which might be expected to 
occur via phagocytosis but we observed the efect in A549 cells, where the mechanism presumably involves the 
T3SS. his suggests that the tetraspanins were not afecting  phagocytosis34 but may be afecting elements of the 
T3SS-mediated entry. CD81 has been shown to be necessary for internalisation of L. monocytogenes in which 
the mechanism involving phosphatidylinositol 4-kinase  II28. CD81 might also afect actin polymerization, e.g., 
CD81 interfaces between the plasma membrane and the cytoskeleton by activating spleen tyrosine kinase, colo-
calizing ezrin-radixin-moesin proteins, and recruiting F-actin to facilitate cytoskeletal reorganization and cell 
 signaling35. CD9 and CD81 have also been shown to be linked to the actin cytoskeleton via their interaction 
partner proteins EWI-2 and EWI-F36. Our data indicate that CD81 plays a signiicant role in MNGC formation 
in both epithelial cells and macrophages. In contrast, the data indicate that CD9 plays this role in macrophage 
cells only. he inding from our CRISPR/Cas9 knockout experiment in A549 cells has consistently conirmed 
the role of CD81 in B. pseudomallei-induced MNGC formation and CD9 in internalization. Although the CD9 
and CD81 genes knockout experiment in J774A.1 cells was not successful, our data suggest that CD9 and CD81 
are involved in B. pseudomallei-induced MNGC formation in this cell. he evidence for this belief comes from 
our consistent results that the antibodies and EC2 proteins of CD9 and CD81 can block B. pseudomallei-induced 
MNGC formation.
Our immunoluorescence and confocal microscopy analyses showed that CD9 and CD81 were distributed 
widely on the cell surface and located with B. pseudomallei during cell fusion. Other studies have also dem-
onstrated the relevance of CD9 and CD81 on cell-to-cell fusion in other conditions. For example, anti-mouse 
CD9 and CD81 MAbs can inhibit sperm-oocyte  fusion37. Gene knockout of CD9 or CD81 in mice could impair 
sperm-egg fusion while double knockout of CD9 and CD81 were completely  interile38. Anti-CD9 MAb can 
inhibit canine distemper virus-induced cell-to-cell  fusion12–15. CD9-EC2 can inhibit monocyte fusion and reduce 
MNGC size in monocytes cultured under fusogenic  conditions39–41. To our knowledge, the role of tetraspanins 
in MNGC formation has never been reported in B. pseudomallei. It is possible that these tetraspanins may not 
directly interact with bacterial molecules during the infection and MNGC formation processes, but they may be 
regulated by other host partner TEM proteins that may directly interact with B. pseudomallei. Other host proteins 
have been shown to be involved with B. pseudomallei infection including E-selectin (CD62E), a fusion regulatory 
protein (CD98), E-cadherin (CD324) integrin (LFA-1) complex, ICAM-1 (CD54), signal-regulatory protein α 
(CD172a), and integrin-associated protein (CD47). Blocking these proteins with speciic antibodies could inhibit 
B. pseudomallei-induced MNGC formation in human leukemic monocyte lymphoma cell  line42. We also showed 
the efects of antibodies to CD47, CD98, and dendritic cell-speciic transmembrane protein (DC-STAMP) on 
B. thailandensis-induced fusion in J774.2  cells16. CD9 and CD81 that are involved in B. pseudomallei-induced 
MNGC formation may be associated with other cell surface molecules that may interact with B. pseudomallei. he 
antibodies and recombinant EC2 proteins target the EC2 regions of the tetraspanins. However, if the mechanism 
of action is afecting signalling in the cells, then this could be by the recruitment of intracellular signalling mol-
ecules via the C-terminal regions of the tetraspanins. Moreover, tetraspanin peptides are active on the host cell 
rather than on the bacteria themselves, as they have no toxicity to the bacteria, e.g., they have no anti-S. aureus 
adherence activity when added to the bacteria before adhesion to host  cells31. Blocking of the EC2 domain of 
tetraspanins by antibodies may interfere with the association between tetraspanins and other partner molecules, 
leading to alteration of TEM organization and  function43. his vital information warrants further investigation.
he efect of anti-tetraspanin MAbs on MNGC formation induced by B. thailandensis was diferent from 
those induced by B. pseudomallei. Speciically, anti-CD9 and anti-CD81 enhanced MNGC formation induced 
by B. thailandensis in both A549 and J774A.1 cells, whereas anti-CD9 and anti-CD81 inhibited MNGC forma-
tion induced by B. pseudomallei, suggesting that the roles of tetraspanins for cell–cell fusion are dependent on 
the microorganism. Although B. thailandensis is a closely-related species to B. pseudomallei and widely used as 
a model to study in melioidosis, our study suggests diferent efects of host tetraspanins transmembrane in the 
bacterial-induced cell fusion of these two species. he mechanism by which tetraspanins are involved in cell–cell 
fusion ater Burkholderia infection is not well understood. Our data and data from other studies suggest that host 
factors and probably bacterial factors seem to be involved in the cell-to-cell spread process. he MNGC formation 
induced by B. pseudomallei or B. thailandensis requires the type VI secretion system (T6SS-5), which is regulated 
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by BsaN, VirAG, and  BprC18,44. his mechanism could lead to cell death by activating autophagy and triggering 
the cGAS-STING pathway via micronuclear  formation20. T6SS-5 plays an essential role in MNGC formation by 
which the C-terminal of VgrG5 processes fusogenic  activity18,45. It is likely that the diferent amino acid sequences 
and conformation of these  factors45,46 might contribute to the interaction with associated tetraspanins. It will be 
of interest to determine the efect of CD9 or CD81 on MNGC formation during infection with B. pseudomallei 
T6SS-5 and VgrG5 mutants in future studies.
It is not clear why MAb treatments were more eicient in inhibition of MNGC formation and subsequent 
reduction of MNGC size than recombinant EC2 protein treatments. A possible explanation is that the MAbs 
may be more speciic to the disruption of tetraspanin function compared to the recombinant EC2 proteins.
Tetraspanins have been reported as a novel treatment for parasitic and bacterial infections. Synthetic peptides 
of tetraspanin, CD9 prevent Staphylococccus aureus skin and wound infections to cultured keratinocytes and 
human skin infection  model31. Our inding suggests that targeting these tetraspanins using speciic antibodies 
or recombinant EC2 proteins could inhibit B. pseudomallei-induced MNGC, thus limited bacterial spreading 
between diferent cell types and that CD9 and CD81 may be good vaccine targets. Antibodies or recombinant 
EC2 proteins may be useful for therapeutic purposes. However, this requires further evaluation in other cell 
types and testing in animal models of melioidosis.
Host and bacterial interplay are complicated, but our study provides insights into the understanding of B. 
pseudomallei-induced cell-to-cell fusion of human epithelial and mouse macrophage cells by which tetraspanins 
are associated with the process by their distribution on the cell surface. Our study in epithelial cells and mac-
rophages revealed that CD9 and CD81 are involved in B. pseudomallei-induced MNGC formation. Antibodies 
speciic to tetraspanins and EC2 proteins could be a potential therapeutic agent to prevent the spread of B. 
pseudomallei to uninfected cells.
Methods
Bacterial strain┸ cell lines┸ and growth conditions┻ B. pseudomallei strain K96243, a clinical isolate, 
and B. thailandensis strain E264, an environmental isolate from hailand, were used in this study. he bacte-
ria were grown on Columbia agar (Oxoid, UK) and incubated at 37 °C overnight. Human lung epithelial cell 
A549 (CCL-185, American Type Culture Collection, MD, USA) was cultured in RPMI 1640 (Gibco BRL, Grand 
Island, NY, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (HyClone, USA). Mouse 
macrophage cell line J774A.1 was cultured in DMEM (Gibco BRL). All cell cultures were performed at 37 °C in 
a humidiied 5%  CO2 incubator. All experiments involving B. pseudomallei were performed in a biosafety level 
3 laboratory.
Antibodies against tetraspanins and recombinant GST fusion proteins┻ hree monoclonal anti-
bodies (MAbs) that recognised human tetraspanins CD9 (clone 602.29), CD63 (clone H5C6), CD81 (clone 1D6, 
Bio-Rad, USA), and IgG1 isotype control (clone JC1) were used to treat A549 cells. MAbs that recognised mouse 
tetraspanins, including MAbs speciic to CD9 (clone MF1, Bio-Rad), CD63 (clone NVG-2, BioLegend Inc., San 
Diego, CA, USA), CD81 (clone Eat2, Bio-Rad), and rat IgG2b, rat IgG2a, and hamster IgG1 isotype controls were 
used to treat J774A.1 cells. he production of recombinant glutathione S-transferase (GST) fusion proteins with 
CD9, CD63, and CD81 tetraspanin EC2 extracellular domains were previously  described30.
Examination of tetraspanin expression┻ Cell surface expression of tetraspanins on A549 and J774A.1 
cells was assessed using low cytometry. he experiment was performed as previously  described30. he cells were 
cultured in the medium for 2 days. To remove cells from culture lasks, A549 cells were trypsinised with 0.25% 
of trypsin–EDTA (Gibco BRL), while J774A.1 cells were dislodged by cell scraper. he cells at a concentration 
of 1.0 × 105 cells were incubated with 5 µg/ml of each primary Mab against tetraspanins, or isotype control at 
4 °C for 1 h. he cells were then washed with PBS followed by incubating with 5 µg/ml secondary antibodies 
(A549: Alexa Fluor 488 conjugated goat anti-mouse antibody (Invitrogen, Waltham, MA, USA) or FITC-con-
jugated anti-rat IgG; J774A.1: anti-hamster IgG (Bio-Rad, USA) at 4 °C for 30 min. he cells were centrifuged 
at 1,000 rpm at 4 °C for 5 min, washed with PBS, and analysed using a FACSCalibur low cytometer (Becton 
Dickinson, Franklin Lakes, NJ, USA). he data was analysed using a Flowjo sotware version 10.1 (FlowJo, LLC). 
Two independent experiments were performed for each experiment.
Adhesion assay┻ A549 and J774A.1 cells were seeded at 1 × 104 cells in 100 µl per well into a 96-well plate 
and incubated at 37 °C for overnight. he cells were pretreated with 20 µg/ml anti-tetraspanin MAbs or recom-
binant EC2 proteins at 37  °C for 1 h, then washed with PBS and infected with B. pseudomallei K96243 at a 
multiplicity of infections per cell (MOI) at 100 for A549 and 30 for J774A.1. he plates were incubated at 37 °C 
with 5%  CO2 for 1 h. Non-adherent bacteria were detached by gentle washes with PBS for 5  times
47, and the cells 
were lysed with 0.1% Triton X-100 (Sigma-Aldrich) for 5 min. he bacterial suspension was serially diluted with 
PBS, spread on Columbia agar, and incubated at 37 °C for 24 h for colony count. he number of adhered bacteria 
was enumerated as colony-forming units (CFU). he percentage of adhesion relected the number of adherent 
bacteria at 1 h post-infection × 100/ the number of CFU added. he percentage of adhesion was calculated from 
three independent experiments; each was conducted in  triplicate47.
In another experiment, J774A.1 cells were pretreated with 2 µg/ml of cytochalasin D (Sigma-Aldrich) for 2 h 
to block  phagocytosis17. he adhesion assay was then performed as described above.
Internalization assay┻ A549 and J774A.1 cells were seeded and pretreated with anti-tetraspanin MAbs 
or recombinant EC2 proteins, as described above. he cells were then washed with PBS and infected with B. 
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pseudomallei at MOI of 100 for A549 and 30 for J774A.1 for 2 h to allow bacterial internalisation. he cells were 
washed with PBS before adding a fresh culture medium containing 250 mg/ml of kanamycin (Gibco BRL). he 
infected cells were further incubated for 2 h to kill residual extracellular bacteria. he infected cells were then 
washed and lysed with 0.1% Triton X-100. he intracellular bacteria were colony counted. he percentage of 
internalization relected the number of intracellular bacteria at 4 h post-infection × 100/ the number of bacteria 
added. he percentage of internalization and MNGC formation was calculated from three independent experi-
ments; each was conducted in  triplicate47.
MNGC formation assay┻ he determination of MNGC formation was performed with B. thailandensis 
E264 and B. pseudomallei K96243, as described by Kespichayawattana W et al.19. A549 and J774A.1 cells were 
seeded in a 96-well plate and pretreated with anti-tetraspanin MAbs or recombinant EC2 proteins, as described 
above. he cells were washed and infected with bacteria at MOI of 100 for A549 cells and 30 for J774A.1 cells 
for 2 h. he extracellular bacteria were then removed, and the cells were further incubated with a fresh cul-
ture medium containing 250 mg/ml of kanamycin. MNGC formation was quantiied ater 12 h of incubation. 
he cells were washed with PBS, ixed with 4% paraformaldehyde in PBS for 30 min, washed again with PBS, 
and stained with Giemsa solution (Merck KGaA, Darmstadt, Germany) for 5  min. he cells were rewashed 
with water and air-dried at RT. he stained cells were imaged with an Operetta High Content analysis system 
(PerkinElmer) and analyzed using ImageJ sotware version 1.52n (https ://rsb.info.nih.gov/ij/). he cells with 3 
nuclei or more were considered to be MNGC. he percentage of MNGC was calculated from many nuclei in 
MNGC × 100/total number of nuclei counted. MNGC size was calculated from the number of nuclei in MNGC/
number of  MNGC40. he percentage of MNGC formation was calculated from three independent experiments, 
each of which was conducted in triplicate.
Immunostaining and confocal microscopy┻ Immunostaining was performed with CD81 for A549 cells 
and CD9 for J774A.1 cell, as previously  described48. A549 or J774A.1cells were seeded at 7 × 105 cells/well on a 
sterile glass coverslip in a 6-well cell culture plate and incubated overnight at 37 °C with 5%  CO2. he monolayer 
of cells was infected with B. pseudomallei at MOI of 25:1 and 10:1 for two h washed with PBS, and further incu-
bating with a medium containing 250 µg/ml of kanamycin for 6 h. he cells were washed with PBS and ixed 
with 4% paraformaldehyde in PBS for 30 min. he cells were permeabilised with 0.5% triton X-100 for 30 min. 
he permeabilised cells were then incubated at 37 °C for 1 h with a mixture of (i) an Alexa Fluor 488 conjugated 
mouse MAb 4B11 speciic to B. pseudomallei capsular  polysaccharide49 at dilution of 1:200, (ii) 20 µg/ml of an 
Alexa Fluor 555 conjugated mouse anti-human CD81 or Alexa Fluor 555 conjugated rat anti-mouse CD9 and 
(iii) Hoechst 33,258 (Invitrogen) at dilution of 1:1000. MAbs 4B11 was conjugated with an Alexa Fluor 488 (Inv-
itrogen) and mouse anti-human CD81 or a rat anti-mouse CD9 antibodies or isotype-matched controls were 
conjugated with an Alexa Fluor 555 according to the manufacturer’s instruction (Invitrogen). Ater three times 
washing with PBS, coverslips were mounted on a glass slide with 8 µl of ProLong Gold antifade reagent (Invit-
rogen). he cells were imaged using a laser scanning confocal microscope (Carl Zeiss LSM 700; Jena, Germany) 
by Z-stack mode with an oil-immersion 100 × objective lens and analysed with a ZEN 2010 version 6.0 sotware.
Generation of tetraspanins knock out cell lines┻ CD9 and CD81 genes knock out were performed 
with A549 and J774A.1 cells using a CRISPR/Cas9  system50. Single guide RNA (sgRNA) sequences targeting 
both mouse and human CD9 and CD81 were designed with appropriate overhangs: sgRNA1 (Human CD9-
Fw 5ƍ-CACC TTA GGG CGC GCG ACC CGC TG-3ƍ and Human CD9-Rw 5ƍ-AAAC CAG CGG GTC GCG CGC 
CCT AA-3ƍ); sgRNA2 (Human CD81-Fw 5ƍ-CACC CCT CCA CTC CCA TGG CGG CG-3ƍ and Human CD81-Rw 
5ƍ-AAAC CGC CGC CAT GGG AGT GGA GG-3ƍ); sgRNA3 (Mouse CD9-Fw 5ƍ-CACC CTG AGA CAC GCT GCG 
GCT AG-3ƍ and Mouse CD9-Rw 5ƍ-AAAC CTA GCC GCA GCG TGT CTC AG-3ƍ); sgRNA4 (Mouse CD81-Fw 
5ƍ- CACC TGG GGA CAG GGC GCA CCC CA-3ƍ and Mouse CD81-Rw 5ƍ-AAAC TGG GGT GCG CCC TGT CCC 
CA-3ƍ). sgRNA sequences targeting both mouse and human CD9 and CD81 were cloned into the Bbs1 site of 
the pSpCas9(BB)-2A-Puro V2.0 (PX459V2.0; Addgene, Cambridge, MA, USA) by using single-step digestion-
ligation and a standard cloning  method51. he inserted gRNA sequences were veriied by direct sequencing. 
A549 or J774A.1 cells were transfected for 24 h with individual plasmids expressing Cas9 and the corresponding 
sgRNA using lipofectamine 3,000 reagent (Invitrogen, Waltham, MA, USA) according to the manufacturer’s 
instruction. Ater transfection, the cells with plasmids were selected by incubating in culture media containing 
puromycin (2 μg/mL) for 48 h. Both CD9 and CD81 negative cells were sorted into a 5 ml polystyrene round-
bottom tube (Corning, New York, USA) using a BD FACSAria III (Becton Dickinson, Franklin Lakes, NJ, USA). 
Single-cell clones were isolated by limiting dilution in a 96 well plate and expanded for gene knockout validation.
Validation of tetraspanins knockout cell lines┻ Genomic DNA was isolated from individual single-
cell clones and non-edited control cells using the Gentra Puregene Blood Kit (Qiagen, Hilden, Germany). PCR 
amplicons spanning the Cas9-sgRNA cleavage site was ampliied in a 25 µl total reaction volume consisting of 
1 µl of 50 ng DNA template, 12.5 µl of KAPA2G Fast Hotstart PCR kit (Kapa Biosystems, Inc., Wilmington, 
MA, USA), 0.5 µl of each 10 µm forward and reverse primers with the following forward and reverse prim-
ers: CD9: CD9F 5ƍ-GCG AGG CCT CCA CGT AAG TC-3ƍ and CD9R 5ƍ-AAC TTA GCC TGG GCC GAA CG-3ƍ; or 
CD81: CD81F 5ƍ- ATA AGT ACT GCG GAG CGA GG-3ƍ and CD81R 5ƍ-CTC CTG GAG CCC ACA GGT GG-3ƍ. he 
PCR conditions were as follows: initial denaturation at 95 °C for 3 min; 34 cycles of denaturation at 95 °C for 
15 s, annealing at 60 °C for 10 s, and extension at 68 °C for 20 s; followed by a inal extension at 68 °C for 5 min. 
he PCR amplicons were run on a 2% agarose gel. Each PCR fragments were puriied and subjected for direct 
sequencing using the forward and reverse PCR.
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Western blot analysis┻ Knock out cells were tested for the presence of CD9 and CD81 at the protein 
level using 15% SDS-PAGE and Western blotting. A549 cells were lysed with 100 µl lysis bufer (25 mM Tris–
HCl pH 7.4 containing 150 mM NaCl, 1% sodium deoxycholate, 1% TritonX-100, 0.1% SDS and 1 mM EDTA 
and 5% glycerol) and 1 µl protease inhibitor (Halt protease and phosphatase inhibitor cocktail (100X) (hermo 
Fisher, Waltham, MA, USA) at 4 °C for 30 min. he lysed cells were centrifuged at 15,000 × g at 4 °C for 15 min. 
he protein concentration of the supernatant was quantiied using a BCA kit (hermo Fisher,  Waltham, 
MA, USA). Cell lysates were diluted with sample bufer and heated at 100 °C for 5 min. hirty µg of protein was 
run on 15% SDS gels, transferred to a nitrocellulose membrane and probed with monoclonal anti-CD9 antibody 
(clone 602.29) or anti-CD81 antibody (clone 1D6, Bio-Rad, USA) at dilution of 1:1000. Rabbit anti-mouse IgG/
HRP (Dako Cytomation, Denmark) at dilution of 1:2000 was used as secondary antibody. BM Chemilumines-
cence Blotting Substrate (Roche, Germany) was added on the membrane before exposure to an X-ray ilm.
Statistical analysis┻ Statistical analysis was performed using GraphPad Prism sotware version 6.0 (Graph-
Pad Sotware Inc, La Jolla, CA). he data are presented as individual points and means ± standard deviation. he 
data were tested for the diference using one-way ANOVA for comparison among three or more groups and t 
tests for comparison between two groups. A statistically signiicant diference was considered at P value < 0.05.
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